Longer term exposure to secondhand smoke and health outcomes in COPD: Impact of urine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol

Nicotine and Tobacco Research

Volumn 11, Issue 8, 2009, Pages 945-953

  Eisner, Mark D ^a   Jacob, Peyton ^a   Benowitz, Neal I ^a   Balmes, John ^a   Blanc, Paul D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANOL; CIGARETTE SMOKE; COTININE; CREATININE;

4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANOL URINE LEVEL; ADULT; AGED; ANALYTICAL PARAMETERS; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; DYSPNEA; EXPOSURE; FEMALE; HEALTH STATUS; HUMAN; IMMOBILIZATION; LONG TERM EXPOSURE; MAJOR CLINICAL STUDY; MALE; PASSIVE SMOKING; PRIORITY JOURNAL; QUALITY OF LIFE; SHORT FORM 12; SHORT TERM EXPOSURE;

AGED; COHORT STUDIES; FEMALE; HEALTH STATUS; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NITROSAMINES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PYRIDINES; TANDEM MASS SPECTROMETRY; TOBACCO SMOKE POLLUTION;

EID: 68049096053     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/ntp091     Document Type: Article

References (51)

1. Alemayehu, B., Aubert, R. E., Feifer, R. A., & Paul, L. D. (2002). Comparative analysis of two quality-of-life instruments for patients with chronic obstructive pulmonary disease. Value in Health, 5, 436-441.
2. Anderson, K. E., Kliris, J., Murphy, L., Carmella, S. G., Han, S., Link, C., et al. (2003). Metabolites of a tobacco-specific lung carcinogen in nonsmoking casino patrons. Cancer Epidemiology, Biomarkers and Prevention, 12, 1544-1546.
3. Barr, R. G., Herbstman, J., Speizer, F. E., & Camargo, C. A., Jr. (2002). Validation of self-reported chronic obstructive pulmonary disease in a cohort study of nurses. American Journal of Epidemiology, 155, 965-971.
4. Benowitz, N. L. (1999). Biomarkers of environmental tobacco smoke exposure. Environmental Health Perspectives, 107 (Suppl. 2), 349-355.
5. Benzo, R., Flume, P. A., Turner, D., & Tempest, M. (2000). Effect of pulmonary rehabilitation on quality of life in patients with COPD: The use of SF-36 summary scores as outcomes measures. Journal of Cardiopulmonary Rehabilitation, 20, 231-234.
6. Bernert, J. T., Jr., Turner, W. E., Pirkle, J. L., Sosnoff, C. S., Akins, J. R., Waldrep, M. K., et al. (1997). Development and validation of sensitive method for determination of serum cotinine in smokers and nonsmokers by liquid chromatography/atmospheric pressure ionization tandem mass spectrometry. Clinical Chemistry, 43, 2281-2291.
7. Blanc, P. D., Eisner, M. D., Balmes, J. R., Trupin, L., Yelin, E. H., & Katz, P. P. (2005). Exposure to vapors, gas, dust, or fumes: Assessment by a single survey item compared to a detailed exposure battery and a job exposure matrix. American Journal of Industrial Medicine, 48, 110-117.
8. Blanc, P. D., Eisner, M. D., Trupin, L., Yelin, E. H., Katz, P. P., & Balmes, J. R. (2004). The association between occupational factors and adverse health outcomes in chronic obstructive pulmonary disease. Occupational and Environmental Medicine, 61, 661-667.
9. Centers for Disease Control and Prevention. (2002). Cigarette smoking among adults - United States, 2000. Morbidity and Mortality Weekly Report, 51, 642-645.
10. Chen, H., Eisner, M. D., Katz, P. P., Yelin, E. H., & Blanc, P. D. (2006). Measuring disease-specific quality of life in obstructive airway disease: Validation of a modified version of the airways questionnaire 20. Chest, 129, 1644-1652.
11. Cleveland, W. S. (1979). Robust locally weighted regression and smoothing scatterplots. Journal of the American Statistical Association, 74, 829-836.
12. Dempsey, D., Tutka, P., Jacob, P., 3rd, Allen, F., Schoedel, K., Tyndale, R. F., et al. (2004). Nicotine metabolite ratio as an index of cytochrome P450 2A6 metabolic activity. Clinical Pharmacology and Therapeutics, 76(1), 64-72.
13. Eisner, M. D., Balmes, J., Katz, P. P., Trupin, L., Yelin, E. H., Blanc, P. D. (2005). Lifetime environmental tobacco smoke exposure and the risk of chronic obstructive pulmonary disease. Environmental Health, 4(1 7.
14. Eisner, M. D., Balmes, J., Yelin, E. H., Katz, P. P., Hammond, S. K., Benowitz, N., et al. (2006). Directly measured secondhand smoke exposure and COPD health outcomes. BMC Pulmonary Medicine, 6, 12.
15. Eisner, M. D., Katz, P. P., Yelin, E. H., Hammond, S. K., & Blanc, P. D. (2001). Measurement of environmental tobacco smoke exposure among adults with asthma. Environmental Health Perspectives, 109, 809-814.
16. Eisner, M. D., Klein, J., Hammond, S. K., Koren, G., Lactao, G., & Iribarren, C. (2005). Directly measured second hand smoke exposure and asthma health outcomes. Thorax, 60, 814-821.
17. Eisner, M. D., Trupin, L., Katz, P. P., Yelin, E. H., Earnest, G., Balmes, J., et al. (2005). Development and validation of a survey based COPD severity score. Chest, 127, 1890-1897.
18. Eisner, M. D., Yelin, E. H., Katz, P. P., Earnest, G., & Blanc, P. D. (2002). Exposure to indoor combustion and adult asthma outcomes: Environmental tobacco smoke, gas stoves, and woodsmoke. Thorax, 57 973-978.
19. Eisner, M. D., Yelin, E. H., Trupin, L., & Blanc, P. D. (2002). The infl uence of chronic respiratory conditions on health status and work disability. American Journal of Public Health, 92, 1506-1513.
20. Garcia-Aymerich, J., Farrero, E., Felez, M. A., Izquierdo, J., Marrades, R. M., & Anto, J. M. (2003). Risk factors of readmission to hospital for a COPD exacerbation: A prospective study. Thorax, 58, 100-105.
21. Hajiro, T., Nishimura, K., Jones, P. W., Tsukino, M., Ikeda, A., Koyama, H., et al. (1999). A novel, short, and simple questionnaire to measure health-related quality of life in patients with chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine, 159, 1874-1878.
22. Hajiro, T., Nishimura, K., Tsukino, M., Ikeda, A., Koyama, H., & Izumi, T. (1998). Analysis of clinical methods used to evaluate dyspnea in patients with chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine, 158, 1185-1189.
23. Hammond, S. K., & Leaderer, B. (1987). A diffusion monitor to measure exposure to passive smoking. Environmental Science and Technology, 21 494-497.
24. Hammond, S. K., Sorensen, G., Youngstrom, R., & Ockene, J. K. (1995). Occupational exposure to environmental tobacco smoke [see comments]. Journal of the American Medical Association, 274, 956-960.
25. Hecht, S. S. (1998). Biochemistry, biology, and carcinogenicity of tobacco-specifi c N-nitrosamines. Chemical Research in Toxicology 11 559-603.
26. Hecht, S. S. (2004). Carcinogen derived biomarkers: Applications in studies of human exposure to secondhand tobacco smoke. Tobacco Control, 13 (Suppl. 1), i48-i56.
27. Hecht, S. S. (2006). A biomarker of exposure to environmental tobacco smoke (ETS) and Ernst Wynder's opinion about ETS and lung cancer. Preventive Medicine, 43, 256-260.
28. Hecht, S. S., Carmella, S. G., Chen, M., Dor Koch, J. F., Miller, A. T., Murphy, S. E., et al. (1999). Quantitation of urinary metabolites of a tobacco-specifi c lung carcinogen after smoking cessation. Cancer Research, 59, 590-596.
29. Hecht, S. S., Carmella, S. G., Le, K. A., Murphy, S. E., Boettcher, A. J., Le, C., et al. (2006). 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol and its glucuronides in the urine of infants exposed to environmental tobacco smoke. Cancer Epidemiology, Biomarkers and Prevention, 15, 988-992.
30. Hecht, S. S., Ye, M., Carmella, S. G., Fredrickson, A., Adgate, J. L., Greaves, I. A., et al. (2001). Metabolites of a tobacco-specific lung carcinogen in the urine of elementary school-aged children. Cancer Epidemiology, Biomarkers and Prevention, 10, 1109-1116.
31. Hukkanen, J., Gourlay, S. G., Kenkare, S., & Benowitz, N. L. (2005). Infl uence of menstrual cycle on cytochrome P450 2A6 activity and cardiovascular effects of nicotine. Clinical Pharmacology and Therapeutics, 77 (3), 159-169.
32. Iribarren, C., Friedman, G. D., Klatsky, A. L., & Eisner, M. D. (2001). Exposure to environmental tobacco smoke: Association with personal characteristics and self reported health conditions. Journal of Epidemiology and Community Health, 55, 721-728.
33. Jacob, P., 3rd, Havel, C., Lee, D. H., Yu, L., Eisner, M. D., & Benowitz, N. L. (2008). Subpicogram per milliliter determination of the tobacco-specifi c carcinogen metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in human urine using liquid chromatography-tandem mass spectrometry. Analytical Chemistry, 80, 8115-8121.
34. Jarvis, M. J., Tunstall-Pedoe, H., Feyerabend, C., Vesey, C., & Saloojee, Y. (1987). Comparison of tests used to distinguish smokers from nonsmokers. A merican Journal of Public Health, 77, 1435-1438.
35. Jones, P. W., & Bosh, T. K. (1997). Quality of life changes in COPD patients treated with salmeterol. American Journal of Respiratory and Critical Care Medicine, 155, 1283-1289.
36. Jones, P. W., Quirk, F. H., Baveystock, C. M., & Littlejohns, P. (1992). A self-complete measure of health status for chronic air-flow limitation. The St. George's Respiratory Questionnaire. American Review of Respiratory Disease, 145, 1321-1327.
37. Kim, J. (1998). Atlas of respiratory disease mortality, United States: 1982-1993. Cincinnati, OH: Department of Health and Human Services, National Institute for Occupational Safety and Health.
38. Mannino, D. M. (2002). COPD: Epidemiology, prevalence, morbidity and mortality, and disease heterogeneity. Chest, 121 (5 Suppl.), 121S-126S.
39. Mannino, D. M., Homa, D. M., Akinbami, L. J., Ford, E. S., & Redd, S. C. (2002). Chronic obstructive pulmonary disease surveillance - United States, 1971-2000. Morbidity and Mortality Weekly Report. Surveillance Summaries, 51 (6), 1-16.
40. Mannino, D. M., Siegel, M., Rose, D., Nkuchia, J., & Etzel, R. (1997) Environmental tobacco smoke exposure in the home and worksite and health effects in adults: Results from the 1991 National Health Interview Survey. Tobacco Control, 6, 296-305.
41. National Center for Health Statistics. (n.d.). National Health Interview Survey. Retrieved March 28, 2008, from http://www.cdc.gov/nchs/about/major/nhis/ quest_data_related_1997_forward.htm
42. Office of Environmental Health Hazard Assessment, California Environmental Protection Agency. (2 005). Health effects assessment for environmental tobacco smoke, Retrieved February 24, 2006, from ftp://ftp.arb.ca.gov/carbis/regact/ets2006/app3part%20b.pdf
43. Osman, L. M., Douglas, J. G., Garden, C., Reglitz, K., Lyon, J., Gordon, S., et al. (2007). Indoor air quality in homes of patients with chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine, 176, 465-472.
44. Sin, D. D., Stafi nski, T., Ng, Y. C., Bell, N. R., & Jacobs, P. (2002). The impact of chronic obstructive pulmonary disease on work loss in the United States. American Journal of Respiratory and Critical Care Medicine, 165, 704-707.
45. Stark, M. J., Rohde, K., Maher, J. E., Pizacani, B. A., Dent, C. W., Bard, R., et al. (2007). The impact of clean indoor air exemptions and preemption policies on the prevalence of a tobacco-specific lung carcinogen among nonsmoking bar and restaurant workers. American Journal of Public Health, 97, 1457-1463.
46. Sternfeld, B., Ngo, L., Satariano, W. A., & Tager, I. B. (2002). Association of body composition with physical performance and self-reported functional limitation in elderly men and women. American Journal of Epidemiology, 156, 110-121.
47. Straus, S. E., McAlister, F. A., Sackett, D. L., & Deeks, J. J. (2002). Accuracy of history, wheezing, and forced expiratory time in the diagnosis of chronic obstructive pulmonary disease. Journal of General Internal Medicine, 17, 684-688.
48. Trupin, L., Earnest, G., San Pedro, M., Balmes, J. R., Eisner, M. D., Yelin, E., et al. (2003). The occupational burden of chronic obstructive pulmonary disease. European Respiratory Journal, 22, 462-469.
49. Tulunay, O. E., Hecht, S. S., Carmella, S. G., Zhang, Y., Lemmonds, C., Murphy, S., et al. (2005). Urinary metabolites of a tobacco-specific lung carcinogen in nonsmoking hospitality workers. Cancer Epidemiology, Biomarkers and Prevention, 14, 1283-1286.
50. Ware, J., Jr., Kosinski, M., & Keller, S. D. (1996). A 12-Item Short-Form Health Survey: Construction of scales and preliminary tests of reliability and validity. Medical Care, 34, 220-233.
51. Ware, J. E., Jr., & Sherbourne, C. D. (1992). The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical Care, 30, 473-483.